GlassScriptPhysician profile
Nikhil Singh
NPI 1417344300
$4,194.99
in general payments reported to CMS, 2019-2025
19 companies · $28.09 in 2025
The $28.09 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $609 · 2020: $527 · 2021: $589 · 2022: $1,887 · 2023: $512 · 2024: $43.00 · 2025: $28.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $583.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $583.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,288.56 | 2019-2023 | Mitraclip |
| Astrazeneca Pharmaceuticals LP | $380.16 | 2020-2022 | |
| Amgen INC. | $335.00 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $204.90 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $177.97 | 2019-2022 | |
| Kestra Medical Technology Services, INC. | $168.40 | 2023 | Assure Wcd |
| Boston Scientific Corporation | $146.79 | 2020-2023 | Lithovue |
| Edwards Lifesciences Corporation | $136.98 | 2022-2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $89.46 | 2019-2024 | Lifevest |
| Lantheus Medical Imaging, INC. | $68.13 | 2020-2022 | |
| Pfizer INC. | $35.41 | 2019 | |
| Heartflow, INC. | $28.09 | 2025 | |
| Abiomed | $28.05 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $24.47 | 2019 | |
| Acist Medical Systems, INC. | $19.00 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals International, Plc | $18.00 | 2024 | Arcalyst |
| Terumo Medical Corporation | $17.79 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $14.62 | 2019 | |
| Merck Sharp & Dohme LLC | $13.21 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nikhil Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.